Results 111 to 120 of about 37,066 (263)

Topics of Interest in Women With Myeloproliferative Neoplasms

open access: yesAmerican Journal of Hematology, Volume 100, Issue S4, Page 74-87, June 2025.
Women with MPN: life‐cycle phases, specific risks, and influencing factors. ABSTRACT Overview Sex and gender have emerged as central modifiers of disease biology, phenotype, and clinical outcomes in myeloproliferative neoplasms (MPNs). This review will uniquely highlight issues affecting women with MPN and articulate their relevant determinants ...
Natasha Szuber   +2 more
wiley   +1 more source

Elucidating the Molecular Landscape of Cystic Kidney Disease: Old Friends, New Friends and Some Surprises

open access: yesAmerican Journal of Medical Genetics Part A, Volume 197, Issue 6, June 2025.
ABSTRACT Cystic kidney diseases (CyKD) are a diverse group of disorders affecting more than 1 in 1000 individuals. Over 120 genes are implicated, primarily encoding components of the primary cilium, transcription factors, and morphogens. Prognosis varies greatly by molecular diagnosis. Causal variants are not identified in 10%–60% of individuals due to
Deborah Watson   +10 more
wiley   +1 more source

Leeching as a substitute for phlebotomy [PDF]

open access: yesBritish Journal of Haematology, 2011
Walter A. Wuillemin, Michael Nagler
openaire   +3 more sources

Sporadic Porphyria Cutanea Tarda, Cutaneous Sarcoidosis, and Compound Heterozygosity of HFE Mutations Cys282Tyr and His63Asp—A Case Report

open access: yeseJHaem, Volume 6, Issue 3, June 2025.
ABSTRACT Porphyria cutanea tarda (PCT) is caused by inherited or acquired defects of uroporphyrinogen decarboxylase (UROD) in the heme biosynthetic pathway. Altered iron homeostasis via hemochromatosis gene (HFE) mutations is one of many susceptibility factors associated with the sporadic form of PCT.
Jowon L. Kim   +3 more
wiley   +1 more source

Inflammation is not the cause of an elevated serum ferritin in non-alcoholic fatty liver disease

open access: yesAnnals of Hepatology, 2014
Background. In non-alcoholic fatty liver disease (NALFD), it has often been assumed that an elevation in serum ferritin is likely related to inflammation rather than iron overload.Material and methods.
Melanie D. Beaton   +2 more
doaj  

Rapid Enoxaparin Adjustment for Childhood Thrombosis/Thromboprophylaxis

open access: yesPediatric Blood &Cancer, Volume 72, Issue 6, June 2025.
ABSTRACT Enoxaparin dosing in children is imperfect and strategies to optimize initial therapy for patients at high‐thrombotic risk would be of clinical benefit. This study looked at using peak‐post‐first‐enoxaparin‐dose anti‐Xa to guide subsequent enoxaparin dose and timing of administration in children deemed high‐thrombotic risk.
Joel Livingston   +7 more
wiley   +1 more source

Population Pharmacokinetics‐Pharmacodynamics and Exposure‐Response of Ropeginterferon Alfa‐2b in Chinese and Japanese Patients With Polycythemia Vera

open access: yesPharmacology Research &Perspectives, Volume 13, Issue 3, June 2025.
ABSTRACT Ropeginterferon alfa‐2b (ropeg) represents a new‐generation interferon‐based therapy approved for polycythaemia vera (PV) treatment. This study aimed to elucidate its population pharmacokinetics‐pharmacodynamics (PopPK‐PD) and exposure‐response (E‐R) relationships.
Albert Qin   +18 more
wiley   +1 more source

Home - About - Disclaimer - Privacy